Latest news
-
Swiss pharma firm's stock rose after it announced dilutive block trade -
Global agencies battling to solve Africa’s glaringly low Covid vaccination rates face indifference, obstinacy and ‘me first’ attitudes in developed world.
-
The world economy is recovering strongly from the pandemic, but low and middle income countries are being left behind. They are looking to the North for vaccines, leniency on debt and fresh development financing
-
US medtech firm raises €5.25bn for acquisition
-
Swiss hospitals are increasingly looking to the local bond market to fund expansion
-
Deutsche Bank is among the firms making a concerted effort to bulk up their capabilities in the healthcare sector, with two managing directors set to join the firm in the coming months.
-
Wells Fargo has informed staff in the US that it is delaying the reopening of its offices in the country as a result of rising Covid-19 cases.
-
MUFG is implementing a new hybrid work policy in EMEA that enshrines flexible working patterns that were introduced during the pandemic.
-
Glenmark Life Sciences, a pharmaceutical ingredients manufacturer, wrapped up a three-day bookbuild for its India IPO on Thursday. The deal, worth up to Rp15.5bn ($208.6m), was covered 15.5 times.
